Paul Hastings Advises on Advanz Pharma’s High-Yield Bond Offering and Additional TLB Facility

Paul Hastings LLP advised a syndicate of initial purchasers led by Goldman Sachs Bank Europe SE and J.P. Morgan Securities plc, including Barclays Bank PLC, Intesa Sanpaolo S.p.A., Jefferies GmbH, Morgan Stanley & Co. International plc and RBC Europe Limited, in connection with the offering of €615 million aggregate principal amount of 7% Senior Secured Notes due 2031 and £250 million aggregate principal amount of 9⅛% Senior Secured Notes due 2031 by Cidron Aida Finco SARL, a portfolio company of private equity firm Nordic Capital and an international specialty pharmaceutical company.

Paul Hastings LLP also advised Goldman Sachs Bank Europe SE, J.P. Morgan SE and Morgan Stanley Bank International Limited as Joint Physical Bookrunners and Barclays Bank PLC, Intesa Sanpaolo S.p.A., Jefferies Finance LLC and Royal Bank of Canada (together with the Joint Physical Bookrunners) as Joint Mandated Lead Arrangers and Joint Bookrunners in connection with the company’s €165 million additional term loan facility.

Partners Ross Anderson and Ed Holmes led the Paul Hastings team, which also included associates Annabel Cawood, Adnane Ayeb, Ben Regan, Naren Kondhia, Hee-Chan Kang and Marine Tabory. The team was also supported by the firm’s Frankfurt office, including partner Dr. J. Melchior Raiser and associate Johannes Hilpert.

About Paul Hastings

With widely recognized elite teams across 17 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers and corporations.